The FDA has authorized the very first COVID-19 test available without a prescription that also detects the flu and Respiratory Syncytial Virus (RSV).

This is the first direct-to-consumer multi-analyte COVID-19 authorized by the FDA and allows users to self-collect a nasal swab sample at home and then send the sample to Labcorp for testing.

The test can identify and differentiate multiple respiratory viruses at the same time, detecting the flu, RSV and COVID-19. 

Results will then be delivered through an online portal with follow-up from a heath care provider for positive or invalid test results.

While the FDA has authorized many at-home COVID-19 tests prior to this one, this is the first time an individual can self-identify their need for a test, order it, collect their sample and send it to a lab, all without contacting a health care professional.

"The rapid advancements being made in consumer access to diagnostic tests, including the ability to collect your sample at home for flu and RSV without a prescription brings us one step closer to tests for these viruses that could be performed entirely at home," said director of the FDA's Center for Devices and Radiological Health, Dr. Jeff Shuren.

The kit can be purchased online or in stores without a prescription. The samples can be self-collected by individuals 18 years old or over, self-collected with adult supervision by those aged 14 years old and over or collected with adult assistance for individuals aged two years old and over. 

This will enable consumers to determine whether or not they have COVID-19 and whether or not self isolation is necessary.